compounding pharmacy glp-1 fda enforcement news today Out of Shortage, Into Controversy: The Fight Over Why the FDA Issued 30

If you're considering GLP-1 therapy without diabetes, understanding your metabolic profile, genetic factors in appetite regulation, and individual risk factors becomes essential

This latest study, published in the JAMA Network, drew on electronic health records of people aged 18 or older with type 2 diabetes and no previous record of smell or taste disturbances

People selling it on TikTok show you PDFs of test results ostensibly proving it is safe to use

However, abuse of IGF-1 LR3 can lead to the infamous bubble gut, which can eventually cause abdominal bloating

doi: 10.1093/ajcn/66.4.911

For best results, use consistently as part of a balanced diet and regular exercise routine